NCT Number: NCT01892982
Improving Preterm Outcomes by Safeguarding Maternal Mental Health
The investigators' goal is to optimize the developmental outcomes of preterm infants by preventing depression and improving functioning among their mothers during the critical first year of life. The investigators are conducting a randomized controlled trial of a replicable, lay-delivered intervention - the basic approach of which is to use an empirically-supported, cognitive behavioral strategy to help mothers solve their unique daily problems and address some of the predictable challenges to parenting a preterm infant.
Looking for future studies?
Notify MeKey information
Conditions
Age range
Up to 64 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
About this study
Preterm infants are born at biological risk for poor health and developmental outcomes; and those born to low-income families face additional social risks known to further interfere with healthy child development. In its 2006 report, Preterm Birth, the Institute of Medicine (IOM) stated the public health importance of optimizing the developmental outcomes of preterm infants, and specifically called for novel postnatal intervention strategies to accomplish this goal. Our proposed strategy is based on the premise that preventing maternal depression - and optimizing maternal functioning in specific domains that mediate the relationship between maternal depression and adverse child effects - will ultimately improve the developmental outcomes of this vulnerable child population.
Problem Solving Education (PSE) is a cognitive behavioral strategy that aims to impart recipients with skills to reduce the impact of stress on personal functioning, and thereby prevent depression. The present project is a randomized trial of a 6-session intervention based on PSE. the investigators aim to enroll 325 mother-infant dyads in four NICUs - Boston Medical Center, Tufts Medical Center, Beth Israel Deaconess Medical Center, and Brigham and Womens Hospital. Over 12-months of follow-up, the investigators will assess the effects of PSE on a series of outcome measures for mothers, a series of measures that represent risk mechanisms by which maternal depression is theorized to impact young children, and a series of child functioning measures.
- Primary aims. Regarding outcomes for mothers, the investigators aim to:
- Decrease the incidence of major depressive episode (MDE) and improve depressive symptom trajectories during the first postpartum year; and
- Improve general and parental functioning, as measured by valid and reliable scales.
- Secondary aims. Regarding risk mechanisms and child outcomes, the investigators aim to:
- Improve mothers' sense of mastery, and decrease their caregiver burden and social isolation;
- Improve adherence to evidence-based quality indicators for NICU follow-up care;
- Improve maternal sensitivity and mother-child interaction patterns; and
- Improve infant social engagement, emotionality, and cognitive functioning.
- Exploratory aims. the investigators will explore the role of a brief set of potential intervention moderators:
- On the infant level: severity of infant illness.
- On the maternal and family level: maternal trauma history, extended family functioning, and intervention adherence.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Baby is 26-34 weeks gestational age
- Baby qualifies to receive Medicaid
- Mother comfortable in English or Spanish
- Singleton or twin gestation
- Baby is expected to survive
Exclusion criteria
- Mother in major depressive episode or endorses suicidality
- Mother with psychosis or otherwise cognitively limited
- Mother with known active substance use; custody of infant uncertain
- Infant is critically ill
- Triplets or higher number gestation
- Mother who is enrolled in another study receiving the same intervention that we are testing
Treatment and study plan
Primary outcomes
-
Incidence of major depressive episode and depressive symptom trajectories
Time frame: one year
To measure depression and depressive symptom trajectories, we will combine a dimensional measure (the Quick Inventory of Depressive Symptoms - QIDS) with the diagnostic Structured Clinical Interview for DSM-IV Disorders (SCID). Administering the QIDS every other month during this time frame will allow us to follow depression symptom trajectories with a repeated measure sensitive to change with treatment. Administering the SCID at 12-months will allow us to determine timing and severity of major depressive episode(s).
-
General Functioning
Time frame: one year
General functioning will be measured by the mean total SAS-SR score, and mean scores for the family, partner, and social SAS subscales. The SAS will be administered at 6 and 12 months of follow-up.
Secondary outcomes
-
Caregiver burden, mastery and social support
Time frame: one year
The Coping Health Inventory for Parents is a valid and reliable instrument designed to measure parents' response to managing family life when they have an ill child. It will be administered together with the Pearlin Mastery Scale and the Medical Outcomes Survey Social Support Scale. Administration of these scales will occur at 6 and 12 months of follow-up.
-
Adherence to recommended NICU follow-up care
Time frame: one year
We assess the following measures of adherence to NICU follow-up care:
- timing and receipt of health supervision visits and immunizations following NICU discharge - including Palivizumab (Synagis).
- ratio of complaint-based to preventive primary care visits; evaluation for, and attendance to, early intervention services.
-
Parent-child interaction
Time frame: one year
We will videotape and microcode a 10-minute mother-infant free play session according to the parent, infant, and dyadic scales of the Coding Interactive Behavior Manual (CIB). We will assess the following composites: maternal sensitivity; intrusive and withdrawn maternal interactions; and depressed mood and positive affect.
-
Socio-emotional functioning
Time frame: one year
We will assess the CIB infant social engagement composite. We will assess negative infant emotionality using the 4-minute 'Mask Task' of the Laboratory Temperamental Assessment Battery (Lab-TAB).
-
Cognitive functioning
Time frame: one year
We will use the MacArthur-Bates Communicative Development Inventory.
Sponsors and collaborators
Lead sponsor
Boston Medical Center
Other
Collaborators
- Beth Israel Deaconess Medical Center
- Brigham and Women's Hospital
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Tufts Medical Center
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Jul 8, 2013
- Registry last updated
- Aug 28, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation of a Home-based Community Health Worker Program in Rural Eastern Cape, South Africa
NCT03517878
Acquired Immunodeficiency Syndrome, Alcohol Drinking
Mqanduli, Eastern Cape, South Africa
View Trial DetailsHealth and Wellness After Preterm Birth
NCT05756634
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsHealthcare Providers as Trusted Messengers to Increase Receipt of Tax Credits Among Low-income Families
NCT05612685
Behavior, Behavioral Symptoms
Los Angeles, California, United States
View Trial DetailsBuilding Regulations in Dual Generations at KIDTHINK
NCT04893850
Behavior, Behavioral Symptoms
Winnipeg, Manitoba, Canada
View Trial Details